You may qualify for this study if you:
- are age 18 or older
- have a diagnosis of vitiligo that involves both sides of the body
Participation involves:
- Phototherapy treatments (3 times per week for 6 months)
- Questionnaires on how vitiligo affects the quality of your life
- Small skin biopsies of your skin
About the study:
Vitiligo is a chronic acquired skin disease of pigmentation that affects patients' quality of life across all degrees of involvement and severity. Phototherapy is a clinically indicated treatment for skin lesions. In this study, we are going to evaluate the efficacy and safety of phototherapy in the treatment of vitiligo as well as impact on quality of life.
For more information, please contact us: 410-502-SKIN ctrep@jhmi.edu
Ginette Okoye, MD, Principal Investigator Johns Hopkins Department of Dermatology IRB Protocol Number: IRB00052103
